WIPO Members Divided On IP Agency’s Role In Implementation Of UN Sustainable Development Goals 02/11/2016 by Catherine Saez, Intellectual Property Watch 1 Comment Countries of the world decided in 2015 to launch an ambitious agenda to end poverty, protect the planet, and ensure prosperity for all by 2030. What should be the role of the UN World Intellectual Property Organization in the attainment of the adopted United Nations Sustainable Development Goals? This question, discussed at the WIPO Committee on Development and IP, is dividing countries, as developed countries argue that only a few goals apply to the work of WIPO, and others argue that there should be no ‘cherrypicking’ as all the goals in one way or another do apply to WIPO’s work as a UN agency.
Mark Whitaker Of Morrison & Foerster Named AIPLA President 01/11/2016 by Intellectual Property Watch 1 Comment Mark L. Whitaker, a veteran intellectual property trial lawyer and partner in Morrison & Foerster’s Intellectual Property Litigation Practice Group in Washington, DC, has been named president of the American Intellectual Property Law Association (AIPLA).
Brazil, China, India, South Africa Put UN High-Level Panel On Medicines Access On TRIPS Council Agenda 31/10/2016 by William New, Intellectual Property Watch Leave a Comment For next week’s World Trade Organization intellectual property committee meeting, the major developing economies have submitted a request to discuss the recently released report of the United Nations Secretary General’s High-Level Panel on Access to Medicines, according to Knowledge Ecology International (KEI). A key element of the UN report was to make it harder for countries deter or discourage other countries from trying to use patent flexibilities built into the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) – something the major developing economies have been discouraged from doing in the past.
GIs: US Industry Claims Harm From Misappropriation Of Common Food Names 28/10/2016 by Alexandra Nightingale for Intellectual Property Watch Leave a Comment Representatives from US dairy trade associations joined the cross-industry Consortium for Common Food Names (CCFN) recently to present an economic analysis on the impact of European Union policies regarding geographical indications on the United States and its dairy industry.
WHO: More Hepatitis C Patients Being Treated In Developing Countries; Price Still An Issue 27/10/2016 by Catherine Saez, Intellectual Property Watch 2 Comments Innovations in medicine bring the hope of cure for millions of patients who can access them. When a novel effective hepatitis C drug was put on the market at very high prices, concerns erupted about access in both developing and developed countries. A new report by the World Health Organization found that over one million people have received new treatment for hepatitis C in developing countries. The report, which targets high prices as a major barrier to access to treatment, also compiles ways countries have overcome the access barriers.
Between Quick Wins And Long Roads Ahead On Antimicrobial Resistance 26/10/2016 by Alexandra Nightingale for Intellectual Property Watch Leave a Comment Raising awareness, creating effective stewardship, national action plans on antimicrobial resistance, building trust and getting onto the agenda of the G20 are critical to fostering access and appropriate use of antibiotics, according to speakers at yesterday’s joint technical symposium on antimicrobial resistance (AMR).
Antimicrobial Resistance Should Not Overshadow Broader Issue Of Access To Medicines, Some Say 26/10/2016 by Catherine Saez, Intellectual Property Watch 1 Comment While the issue of antimicrobial resistance has arrived in high-level discussions, and there is a consensus that the problem must be tackled one way or another to avoid slipping back into a pre-antibiotic era, some voices are highlighting the need to remember that other health issues remain unmet, and access to medicines is still an acute problem.
Antimicrobial Resistance Needs Research, Regulation, Speakers Say 26/10/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The issue of antimicrobial resistance has been in the spotlight in recent months as a growing awareness of the threat it represents for humanity has pushed discussions at the multilateral level. This week, the World Health Organization, World Intellectual Property Organization and World Trade Organization organised a symposium on the subject. Speakers discussed needs and potential solutions.
Freedom To Utilize Genetic Resources? The Nagoya Protocol Two Years Later 24/10/2016 by Guest contributor for Intellectual Property Watch 1 Comment At its second anniversary, the Nagoya Protocol is ushering in an international access and benefit-sharing (ABS) system that may impact the freedom to operate with genetic resources. Those who utilize genetic resources and information should understand the emerging framework and take actions to reduce the risk of patent invalidation, legal liability and reputational harm that may flow from a violation of ABS requirements, writes Bruce S. Manheim.
US High Court Puts Unreasonable Delay On Trial 21/10/2016 by Steven Seidenberg for Intellectual Property Watch Leave a Comment On its face, the case is a humdrum, procedural dispute about a patentee’s delay in filing an infringement suit. But if the Supreme Court rules the way most experts expect, the decision will significantly enhance the power of patent trolls and others alleging patent infringement, and it will harm many companies doing business in the US – especially companies in the tech sector. Much hangs in the balance on 1 November, when the Supreme Court hears oral arguments in SCA Hygiene Products AG v. First Quality Baby Products, LLC.